Teva Earnings Jump 23%

Teva Pharmaceutical’s third-quarter earnings rose a better-than-expected 23%, driven by a jump in profitability in its generic medicine segment.



from WSJ.com: US Business http://ift.tt/13jKeWE

via IFTTT